Sign in
  1. Home
  2. Companies
  3. CVS Health Corporation
  4. Financial Ratios
CVS Health Corporation logo
CVS Health Corporation CVS
$ 96.74 0.12%
report update icon

Quarterly report 2026-Q2
added 08-05-2026

CVS Health Corporation Financial Ratios 2025-2006 | CVS

Brief overview of CVS Health Corporation's financial ratios

Ratios are assessed across five available annual reports in the 2021–2025 interval.

The current valuation set is P/E 54.19x (median 17.47x), EV/EBITDA 28.65x (median 19.02x), P/S 0.24x (median 0.27x). The combined multiple level is about 17.7% above the company's historical norm, leaving less valuation cushion.

Earnings yield calculated as 1/P/E is about 1.8%, showing current profit per unit of share price.

Returns on assets and capital are represented by ROE 2.4%, ROA 0.7%, ROCE 6.2%. Profitability sends a weak positive signal and leaves the business sensitive to cost or demand pressure.

The cash conversion cycle is 37.8 days versus 41.9 days initially. Turnover changed little.

Valuation takeaway

CVS Health Corporation combines weak profitability with valuation above its historical norm, leaving limited cushion.

Annual Financial Ratios CVS Health Corporation

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006

P/E

 54.2 17.4 11.7 27.3 17.5 12.7 13.7 -115.9 12.4 15.9 20.6 24.5 17.9 16.9 16.2 45.8 41.8 19.1 19.4 -

P/S

 0.2 0.2 0.3 0.4 0.5 0.3 0.4 0.4 0.4 0.5 0.7 0.8 0.6 0.5 0.5 0.5 0.4 0.7 0.7 -

EPS

 1.4 3.7 6.5 3.3 6.1 5.5 5.1 -0.6 6.5 4.9 4.7 4.0 3.8 3.0 2.6 0.8 2.6 2.2 2.0 -

EV (Enterprise Value)

 266 B 249 B 262 B 261 B 288 B 244 B 243 B 203 B 138 B 139 B 162 B 148 B 112 B 92.5 B 81.1 B 45.5 B 42.8 B 59.9 B 50.1 B -530 M

EBITDA per Share

 7.31 10.4 14.1 9.28 13.5 14 12.6 12.3 11.8 11.9 10.3 9.24 8.14 7.07 5.9 5.56 5.45 5.1 4.43 -

EV/EBITDA

 28.7 19.0 14.5 21.5 16.2 8.2 9.4 10.7 8.8 8.3 11.5 11.5 9.3 8.2 8.2 6.0 5.5 8.2 8.5 -

PEG

 -6.94 37.88 1.93 -8.2 6.7 1.95 0.01 1.07 0.4 2.74 1.21 4.41 0.76 0.95 5.08 - - - - -

P/B

 1.3 1.1 1.3 1.6 1.9 1.3 1.4 1.2 2.2 2.3 2.9 3.0 2.2 1.7 1.5 0.8 0.7 1.0 - -

P/CF

 9.0 8.8 7.2 7.3 7.7 5.7 8.7 10.1 13.4 10.8 17.9 19.0 21.7 14.1 14.1 9.8 10.9 15.5 15.8 -

ROE %

 2.35 6.11 10.91 6.03 10.69 10.30 10.34 -1.01 17.57 14.44 14.08 12.23 12.10 10.28 9.09 2.72 2.93 9.25 8.42 -

ROA %

 0.70 1.82 3.34 1.89 3.43 3.11 2.98 -0.30 6.96 5.63 5.59 6.25 6.42 5.88 5.36 1.65 1.70 5.25 - -

ROCE %

 6.20 11.27 17.97 11.13 17.78 19.96 7.09 6.67 14.76 15.16 13.41 15.93 14.33 13.87 12.04 16.28 17.96 17.49 15.31 -

Current Ratio

 1.4 1.4 1.4 1.5 1.5 1.4 0.9 1.0 1.0 1.2 1.3 1.4 1.6 1.4 1.6 - - - - -

DSO

 34.6 35.1 31.9 29.3 28.8 28.1 27.9 33.1 26.0 25.0 28.3 25.4 25.1 19.2 20.6 19.8 20.1 11.2 - -

DIO

 30.8 32.0 31.2 34.2 37.6 40.1 30.3 36.8 35.7 36.2 40.3 38.2 39.1 39.0 42.4 50.8 45.7 24.1 - -

DPO

 27.7 27.2 25.0 25.4 24.6 24.1 18.1 20.0 20.7 19.5 21.6 21.0 19.7 18.4 18.4 18.3 17.3 10.0 - -

Operating Cycle

 65.4 67.1 63.1 63.4 66.5 68.2 58.1 69.9 61.8 61.2 68.6 63.6 64.3 58.2 63.0 70.6 65.8 35.4 - -

Cash Conversion Cycle

 37.8 39.8 38.1 38.0 41.9 44.1 40.0 49.9 41.1 41.7 47.1 42.6 44.6 39.8 44.5 52.3 48.6 25.4 - -

All numbers in USD currency

Quarterly Financial Ratios CVS Health Corporation

2026-Q2 2026-Q1 2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1 2010-Q3 2010-Q2 2010-Q1 2009-Q3 2009-Q2

EPS

 2.33 2.31 -3.13 0.81 1.41 - 0.07 1.41 0.88 - 1.76 1.48 1.66 - -2.59 2.31 1.79 - 1.21 2.11 1.69 - 0.93 2.27 1.54 1.34 1.17 1.49 1.09 -0.37 1.36 -2.52 0.98 3.23 1.26 1.07 0.92 1.6 1.44 0.86 1.04 1.35 1.11 1.13 1.08 1.15 0.82 1.07 0.96 1.06 1.03 0.92 0.77 0.91 0.79 0.75 0.59 0.82 0.65 0.6 0.52 0.59 0.61 0.56 0.71 0.61

EBITDA per Share

 4.56 4.55 -1.63 2.81 3.59 - 1.06 3.34 2.71 - 3.26 2.9 3.47 - -2.63 3.91 3.5 - 4.89 3.72 3.58 - 5 5.25 3.48 2.33 4.76 4.24 2.93 0.64 4.4 -0.08 2.6 3.07 4.29 3.3 2.35 2.83 4.37 3.36 2.57 2.48 3.45 2.88 2.32 2.04 3.19 2.72 2.12 1.88 2.93 2.38 1.78 1.87 2.46 2 1.4 1.51 2.07 1.66 1.23 1.9 1.64 1.28 1.82 1.6

ROE %

 3.41 1.98 -1.70 6.10 6.29 3.97 7.01 9.50 10.12 8.62 3.86 4.82 5.40 2.42 4.56 13.12 12.24 9.06 10.82 12.97 12.07 8.94 11.68 12.31 11.06 10.39 6.93 6.92 -0.51 -1.02 8.42 9.44 16.76 17.57 13.48 14.26 13.85 14.44 13.83 13.00 13.91 14.08 13.53 12.68 12.54 12.23 12.09 12.88 12.56 12.10 11.76 11.13 10.72 10.25 10.06 9.70 9.29 9.12 8.53 8.51 8.54 9.52 9.76 2.16 2.86 2.45

ROA %

 1.18 0.70 -0.43 1.83 1.88 1.18 2.08 2.81 3.00 2.55 1.08 1.19 1.11 0.22 1.43 2.90 3.87 2.86 3.39 4.00 3.66 2.69 3.48 3.63 3.21 2.98 1.98 2.00 -0.17 -0.30 3.37 4.01 6.47 6.96 5.31 5.59 5.42 5.63 5.44 5.16 5.56 5.67 5.83 5.76 6.06 6.26 6.25 6.71 6.61 6.42 6.35 6.13 6.02 5.85 5.79 5.61 5.42 5.35 5.02 5.01 5.01 5.55 5.70 1.26 1.65 1.45

ROCE %

 10.62 9.11 4.18 12.63 12.61 8.23 13.18 16.50 17.26 14.20 8.71 9.93 10.29 5.47 9.57 20.94 19.80 15.01 19.69 22.33 21.44 16.41 21.17 21.07 19.54 18.77 15.43 15.27 7.69 6.91 13.75 15.98 23.96 25.31 25.19 26.21 26.99 28.15 27.34 25.94 25.62 25.42 24.19 23.84 23.58 23.18 22.91 22.67 22.05 21.18 21.45 20.57 19.89 19.13 18.17 17.59 16.96 16.70 15.60 15.56 15.63 16.57 16.95 3.95 4.39 4.43

Current Ratio

 1.5 1.4 1.4 1.4 1.4 1.4 1.4 1.4 1.4 1.4 1.4 1.4 1.4 1.5 1.4 - 1.5 1.5 1.5 1.5 1.4 1.4 1.4 1.4 1.4 1.4 1.4 1.4 1.4 1.4 1.4 1.4 1.4 1.7 1.7 1.7 1.7 - - - - - - - - - - - - - - - - - - - - - - - - - - - 2.4 -

DSO

 35.0 38.5 37.5 37.0 36.7 - 32.8 32.3 34.8 - 31.8 29.7 29.8 - 14.8 15.0 30.2 - 30.6 30.2 30.1 - 29.6 30.4 28.3 26.8 27.6 28.2 27.6 29.6 33.9 34.3 30.7 24.9 26.0 26.3 26.0 24.1 24.9 25.4 25.4 26.4 28.1 29.2 27.1 23.9 25.2 25.6 25.7 24.3 24.9 25.5 22.6 18.8 19.5 19.2 18.6 19.5 20.7 20.9 19.8 19.5 19.5 20.8 20.8 -

DIO

 27.4 30.2 29.1 29.4 31.7 - 29.1 29.6 32.6 - 29.4 30.3 33.1 - 16.4 16.8 36.0 - 34.9 36.3 40.3 - 41.2 41.9 40.7 - 39.5 41.0 41.6 - 38.0 38.6 38.6 - 35.7 36.0 36.1 - 36.3 36.7 36.0 - 40.0 41.5 39.2 - 38.1 38.5 39.2 - 38.9 39.7 40.0 - 39.9 38.9 37.0 - 42.6 43.0 44.9 50.8 49.6 48.6 45.0 -

DPO

 26.4 28.5 28.0 28.6 29.0 - 26.0 25.7 27.2 - 23.6 22.1 24.3 - 12.6 11.8 25.4 - 24.1 22.9 24.5 - 24.8 25.3 24.5 - 23.7 24.6 23.8 - 20.1 19.1 20.2 - 19.6 20.9 20.2 - 19.5 19.8 19.3 - 21.4 22.2 21.2 - 20.9 21.1 20.6 - 19.5 19.9 19.2 - 18.8 18.3 16.8 - 18.6 18.7 18.6 19.4 19.0 19.2 9.2 -

Operating Cycle

 - - - 66.5 68.4 - 61.8 61.9 67.4 - 61.1 60.0 62.9 - 31.1 31.8 66.2 - 65.4 66.4 70.4 - 70.8 72.3 69.0 26.8 67.2 69.2 69.2 29.6 71.9 72.9 69.3 24.9 61.8 62.4 62.1 24.1 61.2 62.1 61.4 26.4 68.0 70.7 66.3 23.9 63.4 64.0 64.9 24.3 63.9 65.2 62.6 18.8 59.5 58.1 55.5 19.5 63.3 63.9 - - - - - -

Cash Conversion Cycle

 - - - 37.9 39.4 - 35.9 36.2 40.2 - 37.6 37.9 38.6 - 18.5 20.0 40.9 - 41.4 43.5 45.9 - 46.0 47.0 44.5 26.8 43.5 44.7 45.4 29.6 51.8 53.8 49.1 24.9 42.2 41.5 41.9 24.1 41.6 42.3 42.1 26.4 46.6 48.5 45.1 23.9 42.5 42.9 44.3 24.3 44.3 45.2 43.3 18.8 40.6 39.8 38.7 19.5 44.8 45.2 - - - - - -

All numbers in USD currency

Multiples are an important financial analysis tool for the company CVS Health Corporation, allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.

Advantages of Using Financial Ratios
  • Simplified Data Analysis
    Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition.
  • Comparability Between Companies
    Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations.
  • Identification of Trends and Issues
    Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks.
  • Decision Support
    Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions.
  • Accelerated Assessment of Investment Attractiveness
    Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.

Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.

Financial Ratios of other stocks in the Health care industry

Issuer Price % 24h Market Cap Country
Triple-S Management Corporation Triple-S Management Corporation
GTS
 		- 0.28 % $ 847 M usaUSA
Magellan Health, Inc. Magellan Health, Inc.
MGLN
 		- -0.19 % $ 2.49 B usaUSA
Anthem Anthem
ANTM
 		- -2.32 % $ 107 B usaUSA
Cigna Corporation Cigna Corporation
CI
 		$ 282.52 1.21 % $ 74.4 B usaUSA
Centene Corporation Centene Corporation
CNC
 		$ 67.04 1.01 % $ 33.1 B usaUSA
Humana Humana
HUM
 		$ 401.54 0.21 % $ 48.4 B usaUSA
Molina Healthcare Molina Healthcare
MOH
 		$ 200.8 0.14 % $ 10.6 B usaUSA
NovoCure Limited NovoCure Limited
NVCR
 		$ 17.94 1.7 % $ 2 B jerseyJersey
UnitedHealth Group Inc. UnitedHealth Group Inc.
UNH
 		$ 397.14 0.32 % $ 361 B usaUSA